Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra Leone.
Africa
Ebola virus
IgG
Sierra Leone
antibodies
risk factors
seroprevalence
viruses
zoonoses
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
03 2022
03 2022
Historique:
entrez:
24
2
2022
pubmed:
25
2
2022
medline:
2
4
2022
Statut:
ppublish
Résumé
We explored the association of Ebola virus antibody seropositivity and concentration with potential risk factors for infection. Among 1,282 adults and children from a community affected by the 2014-2016 Ebola outbreak in Sierra Leone, 8% were seropositive for virus antibodies but never experienced disease symptoms. Antibody concentration increased with age.
Identifiants
pubmed: 35202536
doi: 10.3201/eid2803.211496
pmc: PMC8888237
doi:
Substances chimiques
Glycoproteins
0
Immunoglobulin G
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
734-738Références
J Virol Methods. 2018 May;255:84-90
pubmed: 29481881
J Infect Dis. 2018 Nov 22;218(suppl_5):S305-S311
pubmed: 29982580
Transbound Emerg Dis. 2020 Mar;67(2):724-732
pubmed: 31627257
Int J Epidemiol. 2016 Feb;45(1):102-16
pubmed: 26589246
PLoS Negl Trop Dis. 2019 Jul 22;13(7):e0007614
pubmed: 31329600
Lancet Infect Dis. 2022 Jan;22(1):97-109
pubmed: 34529963
Am J Trop Med Hyg. 1983 Nov;32(6):1465-6
pubmed: 6650749
Sci Data. 2017 Jan 31;4:160133
pubmed: 28140390
Emerg Infect Dis. 2020 Apr;26(4):760-763
pubmed: 32186496
Lancet Infect Dis. 2022 Jan;22(1):110-122
pubmed: 34529962
N Engl J Med. 2017 Oct 12;377(15):1438-1447
pubmed: 29020589
BMC Infect Dis. 2016 Jun 10;16:263
pubmed: 27286990
Science. 2009 Jul 10;325(5937):204-6
pubmed: 19590002
Sci Rep. 2012;2:811
pubmed: 23155478